1470189-67-3

Upstream product

• 293744-38-4 tert-butyl 4-(1H-imindazole-1-carbonyl)piperidine-1-carboxylate 
• 1470189-63-9 tert-butyl 4-(3-methyl-1-(4-sulphamoylphenyl)-1H-pyrazol-5-yl)piperidine-1-carboxylate 
• 419571-68-9 4-(3-oxo-butyrl)-piperidine-1-carboxylic acid tert-butyl ester 
• 84358-13-4 N-[(tert-butoxy)carbonyl]piperidine-4-carboxylic acid 
• 498-94-2 isonipecotic acid 

Downstream Products

• 1470189-81-1 4-(5-(1-benzoylpiperidin-4-yl)-3-methyl-1H-pyrazol-1-yl)benzenesulphonamide 
• 1470189-83-3 4-(5-(1-(4-chlorobenzoyl)piperidin-4-yl)-3-methyl-1H-pyrazol-1-yl)benzenesulphonamide 
• 1470189-85-5 4-(3-methyl-5-(1-(4-methylbenzoyl)piperidin-4-yl)-1H-pyrazol-1-yl)benzenesulphonamide 
• 1470189-87-7 4-(5-(1-(4-methoxybenzoyl)piperidin-4-yl)-3-methyl-1H-pyrazol-1-yl)benzenesulphonamide 
• 1470189-89-9 4-(3-methyl-5-(1-(4-nitrobenzoyl)piperidin-4-yl)-1H-pyrazol-1-yl)benzenesulphonamide 
• 1470189-91-3 4-(3-methyl-5-(1-propionylpiperidin-4-yl)-1H-pyrazol-1-yl)benzenesulphonamide 
• 1470189-93-5 N-ethyl-4-(3-methyl-1-(4-sulphamoylphenyl)-1H-pyrazol-5-yl)piperidine-1-carboxamide 
• 1470189-95-7 4-(3-methyl-1-(4-sulphamoylphenyl)-1H-pyrazol-5-yl)-N-propylpiperidine-1-carboxamide 
• 1470189-97-9 N-isopropyl-4-(3-methyl-1-(4-sulphamoylphenyl)-1H-pyrazol-5-yl)piperidine-1-carboxamide 
• 1470189-99-1 N-butyl-4-(3-methyl-1-(4-sulphamoylphenyl)-1H-pyrazol-5-yl)piperidine-1-carboxamide 
• 1470190-01-2 N-cyclohexyl-4-(3-methyl-1-(4-sulphamoylphenyl)-1H-pyrazol-5-yl)piperidine-1-carboxamide 
• 1470190-03-4 N-phenyl-4-(3-methyl-1-(4-sulphamoylphenyl)-1H-pyrazol-5-yl)piperidine-1-carboxamide 
• 1470190-05-6 4-(3-methyl-1-(4-sulphamoylphenyl)-1H-pyrazol-5-yl)-N-p-tolylpiperidine-1-carboxamide 
• 1470190-07-8 N-benzyl-4-(3-methyl-1-(4-sulphamoylphenyl)-1H-pyrazol-5-yl)piperidine-1-carboxamide 

Relevant academic research and scientific papers

Design, synthesis and biological evaluation of 4-(1- (4(sulphanilamide) phenyl)-3-(methyl)-1H-pyrazol-5-yl)dine urea and N-acyl derivatives as a soluble epoxide hydrolase inhibitors

A series of novel sEH inhibitors containing a N-substituted piperidine ring [N-urea (8a-i ) (9a-l) and amide derivatives (6a-l) (7a-l )] with pyrazole (a five-membered polar heterocycle) as a pharmacophore lead for sEH inhibition have been designed, synth